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Research question: Can carnosic acid, (CA) rosmarinic acid (RA) and wogonin (WG) inhibit the 
growth of cultured human endometrial stromal cells and endometriotic-like lesions induced in a 
BALB/c model of endometriosis? 
Design: Primary stromal cell cultures were established from endometrial biopsies from women 
with endometriosis and controls. The human endometrial stromal cell line T-HESC was also used 
for in-vitro experiments. Endometriosis was surgically induced in BALB/c mice, which were 
randomly assigned to CA 2 mg/kg/day (n = 11); CA 20 mg/kg/day (n = 10); RA 1 mg/kg/day (n 
= 11); RA 3 mg/kg/day (n = 10); WG 20 mg/kg/day (n = 12); intraperitoneal vehicle control (n = 
8) or oral vehicle control (n = 11). After surgery, CA and RA were administered intraperitoneally 














Results: CA, RA and WG significantly inhibited in-vitro cell proliferation in primary and T-
HESC cell cultures (P < 0.05). CA and WG induced cell cycle arrest of T-HESC at the G2/M 
phase (P < 0.01). RA reduced intracellular ROS accumulation (P < 0.001), whereas WG 
increased it (P < 0.05). WG significantly inhibited oestrogen receptor alpha expression in T-
HESC (P < 0.01). In-vivo, CA, RA and WG significantly reduced lesions size (P < 0.05). All 
compounds significantly decreased the percentage of cells in proliferation (P < 0.05) whereas RA 
and WG further increased the percentage of apoptotic cells (P < 0.05) in endometriotic-like 
lesions. 
Conclusions: The results are promising; further investigation of these compounds as new 
therapeutics is needed. 
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Introduction 
Endometriosis is a chronic disease characterized by the presence of endometrial tissue outside the 
uterine cavity. This gynaecological disorder affects around 6–10% of reproductive-age women 














(Giudice and Kao, 2004). The most characteristic symptoms of endometriosis are pelvic pain and 
infertility. Pain, manifested as chronic pelvic pain, dysmenorrhoea and dyspareunia, is frequently 
intolerable and profoundly affects the quality life of patients and often recurs, even after 
treatment (Vercellini et al., 2014). Current medical treatments have important disadvantages, 
including a high rate of disease recurrence and adverse effects that limit their long-term use 
(Vercellini et al., 2014). 
 
Ectopic endometrial tissue, as well as eutopic tissue, responds to oestrogens and can proliferate 
and survive outside the uterine cavity. Oestrogen enhances the survival of endometriotic tissue, 
whereas prostaglandins and cytokines mediate pain, inflammation and infertility (Bulun, 2009; 
Burney and Giudice, 2012). In addition, chronic inflammation is associated with increased levels 
of reactive oxygen species (ROS) in endometriosis (Van Langendonckt et al., 2002; Ngô et al., 
2009; Nasiri et al., 2016). 
Although endometriosis is a benign disorder, the process by which endometrial cells attach and 
invade surfaces shares features of malignancy (Burney and Giudice, 2012). Recent advances in 
cancer research have focused on the use of extracts and bioactive compounds present in plants 
(Shanmugam et al., 2011; Ravishankar et al., 2013). It is well known that natural polychemical 
mixture of pharmacologically active compounds may target multiple vulnerabilities of cancer 
cells, without toxicity to the non-cancerous cells (Ovadje et al., 2015). The use of natural 
compounds provides the possibility of long-term administration with little to no associated 
toxicity to patients (Shanmugam et al., 2011). The present study, and other studies in 
endometriosis, also support further investigation of novel, potentially safe and well-tolerated 
botanical products as innovative therapeutics (Wieser et al., 2012; Ricci et al., 2013; Harlev et 















The phenolic diterpene carnosic acid (Figure 1A) and the polyphenol rosmarinic acid (Figure 
1B) are the most abundant active compounds in rosemary (Rosmarinus officinalis) leaves and are 
responsible for the anti-oxidant activity of this plant (Moore et al., 2016). Several studies have 
recently demonstrated their anti-tumoural (López-Jiménez et al., 2013; Moore et al., 2016) and 
anti-inflammatory ( Yesil-Celiktas et al., 2010; Petiwala and Johnson, 2015) effects. 
 
SImilarly, it is known that Chinese herbal medicine is being used for patients with endometriosis 
and it has had favourable results in decreasing symptoms and increasing fertility (Flower et al., 
2012; Stephens et al., 2013; Su et al., 2014; Ried, 2015). On the basis of this evidence, recent 
studies have aimed to evaluate wogonin (Figure 1C), one of the most important bioactive 
molecules of Chinese herbal medicine. Wogonin is a flavonoid isolated from the root of the 
medicinal herb Huang-Qin (Scutellaria baicalensis). Its anti-tumoural, anti-proliferative, anti-
inflammatory and pro-apoptotic properties have already been demonstrated in different studies 
(Li-Weber, 2009; Wu et al., 2016). Its effects on endometriosis inhibition, however, have not yet 
been investigated. 
 
Therefore, the aim of our study was to evaluate the effect of carnosic acid, rosmarinic acid and 
wogonin in-vitro and in-vivo on the development of experimental endometriosis. 
 















A total of 17 reproductive-age patients who underwent diagnostic laparoscopy for infertility 
participated in this study: eight with untreated endometriosis (Stages II, III and IV, ASRM, 
1997), and nine controls. Confirmation of endometriosis was by histological documentation. 
Control participants included women without endometriosis or any pathology that could affect 
the evaluated cell population, with tubal factor or unexplained infertility, undergoing diagnostic 
laparoscopy. All patients were infertile, had regular menstrual cycles and had not received any 
hormonal medical treatment for the last 6 months. All participants signed informed consent 
before enrolment. Biopsies of eutopic endometrium were obtained from all participants in the 
proliferative phase as described previously (Meresman et al., 2000). This study was approved by 
the Ethics and Research Committee of the IBYME-CONICET on 18 August 2016 (reference CE 
11 - Julio/2016). 
 
Isolation and culture of endometrial stromal cells 
Endometrial stromal cells were isolated from endometrial biopsies of patients with endometriosis 
and controls. Stromal cells were enzymatically isolated by successive centrifugations, and 
primary cultures were established for in-vitro studies. Briefly, tissue was minced, washed and 
placed in Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F-12, Gibco, 
Fisher Scientific, Loughborough, UK) supplemented with antibiotic–antimycotic (Gibco) and 
collagenase 0.5 mg/ml (type I, Gibco). After 2 h of incubation at 37°C in a 5% CO2 atmosphere, 
the resulting suspension was centrifuged at 400 x g for 5 min. The pellet containing epithelial 
glands and stromal cells was resuspended in culture medium and filtered through a 40 µm cell 
strainer (BD Falcon
TM
, USA). The solution containing mainly stromal cells was recovered and 














supplemented with 10% fetal bovine serum (FBS) (Gibco) in a humidified environment with 5% 
CO2 at 37°C. Purity of the culture was determined by vimentin immunostaining, resulting in a 
90% stromal-cell culture (data not shown). 
 
Cell line and culture conditions 
Telomerase-immortalized Human Endometrial Stromal Cell line (T-HESC, ATCC CRL-4003, 
USA) was cultured in 10% FBS DMEM/F-12 in a humidified 5% CO2 incubator at 37°C. 
 
Cell proliferation assay 
Five thousand T-HESC cells per well and 1.5 x 10
4
 endometrial stromal cells per well from 
patients and controls were individually plated in 96-well culture plates with 10% FBS 
DMEM/F12 and incubated at 37°C in a 5% CO2 atmosphere. When cells reached 70% 
confluence, cultures were washed and incubated for 24 h with different concentrations of each 
compound in fresh 1% FBS medium. The evaluated treatments were: 2.5, 5, 7.5, 10, 12.5 and 25 
µg/ml of carnosic acid (Alexis biochemicals, San Diego, CA, USA); 25, 50 and 100 µg/ml of 
rosmarinic acid (Enzo Life Sciences, Farmingdale, NY, USA) and 40, 80 and 160 µM of 
wogonin (Sigma-Aldrich
TM
, St Louis, MO, USA). Basal conditions were obtained by incubating 
cells with the vehicles used to dissolve each compound: dimethyl sulphoxide (DMSO) (Sigma-
Aldrich) at a final concentration less than 0.8% for carnosic acid and wogonin, and phosphate 
buffered saline (PBS) for rosmarinic acid. Each treatment condition was run in quadruplicate. 














Solution Cell proliferation kit ([3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium], MTS, Promega Corp., Fitchburg WI, USA) as previously 
described (Ricci et al., 2013).  
 
Cell cycle analysis 
For cell cycle analysis 2.5 x 10
5
 T-HESC cells per well were plated in 6-well culture plates with 
10% FBS DMEM/F12. After 24 h, cultures were washed and incubated for an additional 48 h 
with carnosic acid (0, 2.5 and 5 µg/ml), rosmarinic acid (0, 50 and 100 µg/ml) or wogonin (0, 40 
and 80 µM) in 1% FBS-supplemented medium. Next, the cells were harvested using trypsin 
0.25% (Gibco) and centrifuged at 250 x g for 5 min. Supernatant was removed, cells were 
washed with ice-cold PBS, and fixed with ice-cold 70% ethanol. Cells were kept at –20 °C until 
assayed. Then, cells were centrifuged at 100 x g for 5 min and the supernatant was removed. The 
cell pellet was carefully resuspended adding 50 µg/ml propidium iodide in PBS. Cells were kept 
in the dark for 15 min and cell cycle distribution was determined using a flow cytometer (FACS 
Canto II, BD Biosciences, San Jose, CA, USA). Cyflogic1.2.1 software was used to analyse the 
results. All treatments were compared with control condition incubated with vehicle.  
 
Determination of intracellular reactive oxygen species levels 
2’,7’-Dichlorodihydrofluorescein diacetate (H2DCF-DA) (Sigma-Aldrich) was used to assess the 
intracellular ROS levels (Rossi et al., 2016). After penetration into the cells, the non-fluorescent 
ester was hydrolyzed to 2’,7’-dichlorodihydrofluorescein (H2DCF) by cellular esterases. H2DCF 














intracellular ROS. Six thousand T-HESC cells per well were plated in 96-well black/clear bottom 
culture plates. After a 24-h treatment with carnosic acid (0; 2.5; 5; 7.5 and 10 µg/ml), rosmarinic 
acid (0; 50 and 100 µg/ml) or wogonin (0; 40 and 80 µM), cells were incubated in a medium 
containing 10 μM H2DCF-DA for 30 min in the dark at 37°C and 5% CO2. Dichlorofluorescein 
(generation was measured every 5 min for 70 min at 37°C using a spectrofluorometer (Molecular 
Devices Spectramax Gemini EM) at 485 nm excitation and 530 nm emission. The ∆fluorescence 
was calculated by subtracting the average fluorescence intensity at 0 min to the average 
fluorescence intensity at 70 min. To include an anti-oxidant control, cells were pre-treated with 5 
mM of N-acetyl-cysteine, a ROS scavenger, for 1 h and then the highest dose of wogonin was 
added. 
Western blot 
A total of 2.5 x 10
5
 T-HESC cells per well were plated in 6-well culture plates with 10% FBS 
DMEM/F12. After 24 h, cultures were washed and incubated for an additional 48 h with carnosic 
acid (0, 2.5 and 5 µg/ml), rosmarinic acid (0, 50 and 100 µg/ml) or wogonin (0, 40 and 80 µM) in 
1% FBS-supplemented medium. Cells were then lysed by scraping in chilled lysis buffer (50 mM 
Tris-HCl pH 7.5, 1 mM EDTA, 1 mM EGTA, 150 mM NaCl, 10% glycerol, 1% NP40, 1mM 
MgCl2, 0.1% SDS)
 
supplemented with protease inhibitors (1:500, Sigma). After freeze thawing, 
the lysate was centrifuged at 15, 000 x g for 10 min at 4°C, and the pellet was discarded. Protein 
concentrations in the supernatant were measured by the Bradford assay (Bradford, 1976). Fifty 
μg of proteins were separated from each sample and subjected to a 12% polyacrylamide gel 
electrophoresis for about 90 min at 150 V. The separated proteins were transferred to a 2 µm 
nitrocellulose membrane (Hybond ECL, Amersham Biosciences), which was blocked for 1 h in 














oestrogen receptor alpha primary antibody (1:250, clone MC-20, Santa Cruz Biotechnology, 
Dallas, TX, USA) or glyceraldehyde 3-phosphate dehydrogenase antibody (1:10000, clone 
14C10, cell signalling) diluted in 1% low-fat powdered milk in 0.01% tween in tris buffer saline 
at 4°C, followed by the peroxidase-conjugated secondary antibody (anti-rabbit IgG, 1:2000, 
Sigma) diluted in tween in tris buffer saline at room temperature for 1 h. Protein bands were 
visualized by chemiluminescence, incubating the membranes for 1 min with the ECL 
chemiluminescent reagent (Pierce). The images of the bands were digitally acquired (G-Box, 
SynGene). The quantification was carried out by densitometric analysis of the bands, using the 
Image J software (NIH), normalized with the glyceraldehyde 3-phosphate dehydrogenase 
expression in each well. 
 
Measurement of oestradiol by enzyme-linked immunosorbent assay 
 
 
Oestradiol levels were measured in conditioned media from T-HESC cell cultures treated for 48 h 
with wogonin (0, 40, 80 μM) using a commercial enzyme-linked immunosorbent assay (ELISA) 
kit and following the procedures detailed by the manufacturer (Estradiol ELISA kit, Cayman 
Chemical, Ann Arbor, MI, USA). The conditioned media was centrifuged (5 min, 100 x g) and 
the supernatants were maintained at –20°C. Before the test, steroid hormones were extracted 
using ethyl ether. Briefly, the conditioned media was shaken for 1 min in conical glass tubes after 
adding ethyl ether in a 1:2 ratio and incubated at –70°C for 1 h. Then, the ether phase was 














again to the initial tube and the steps mentioned above were repeated. Once the evaporation of the 
ether was completed, the extracts were stored at –70 °C until the day on which the ELISA was 
carried out. The oestradiol quantification was carried out according to procedures detailed by the 
manufacturer. The sensitivity level for the oestradiol ELISA was 15 pg/ml. A spectrophotometer 
(Labsystems Multiscan, Midland, ON, Canada) was used to record absorbance at 405 nm. All 
samples were assessed in duplicate. 
 
Animals 
In this study, 77 2-month-old female BALB/c mice, weighing 20–24 g were used. All procedures 
were carried out according to the National Institutes of Health Guide for the care and use of 
laboratory animals and approved by the CICUAL Committee from the IBYME-CONICET on 18 
August 2016 (reference CE 11 - Julio/2016). A total of four animals died or were killed 2 or 3 
days after surgery because they did not fully recover from the procedure. 
All animals were weighed every other day so that they received the correct dose of the 
corresponding treatment. This measurement also served as a control for their overall wellbeing. 
Additionally, animals were carefully observed to detect any changes in their grooming behaviour, 
activity levels and food consumption from post-surgical day 1 up to day of sacrifice. 
During treatment, vaginal smears were obtained to check oestrous cycle progression. A total of 
20 µl saline solution was introduced to the vaginal canal and the withdrawn solution was 
mounted on a slide and observed microscopically for cytological staging. This procedure was 















Surgical induction of endometriosis and treatment 
Endometriosis-like lesions were induced through transplantation of one of the uterine horns to the 
bowel mesentery as previously described (Olivares et al., 2011). All treatments started on 
postoperative day 14, at which point the endometriotic lesions were already developed (Nisolle et 
al., 2000). Carnosic acid and rosmarinic acid were administered intraperitoneally over 14 
consecutive days; wogonin was administered orally by intragastric gavage over 12 consecutive 
days. 
Carnosic acid (Enzo Life Sciences, USA) was dissolved in dimethyl sulfoxide (DMSO) and 
diluted in physiological solution (0.8% DMSO final concentration). Rosmarinic acid (Enzo Life 
Sciences) was dissolved in PBS. Both treatments shared the control group, which received 
vehicle (control intraperitoneal 0.8% DMSO in physiological solution). Wogonin (Enzo Life 
Sciences) was partially resuspended in DMSO and diluted in physiological solution for its 
administration (1.6% DMSO final concentration); its control group received vehicle by the same 
route of administration (control oral). Treatment groups, doses and routes of administration are 
presented in Table 1.  
Because of the lack of research on the bioavailability of these compounds after oral 
administration, carnosic acid and rosmarinic acid were administered intraperitoneally to observe 
a local and direct effect. Wogonin was administered orally because it is difficult to dissolve.  
 














Animals were sacrificed by cervical dislocation 24 h after the last injection. The abdomen was 
opened by ventral midline incision. Implantation sites were localized by the presence of a lesion 
or by suture alone. Lesions were counted and measured for volume determination using the 
formula: V= (4/3)πr
2
R (where r and R are the radiuses, r<R) (Brodie et al., 2003). Then, lesions 
were excised and fixed in 4% formaldehyde, paraffin-embedded and cut into 5-µm serial sections 
for histological analysis. Several sections from each specimen were stained with haematoxylin 
and eosin, and examined microscopically for the presence of histological hallmarks (glands and 
stroma) of endometriosis.  
 
Immunohistochemistry for proliferating cell nuclear antigen  
Serial sections of endometriotic-like lesions were subjected to standard immunohistochemistry 
procedures for proliferating cell nuclear antigen (PCNA) as described previously (Olivares et al., 
2011) using rabbit anti-mouse PCNA polyclonal (1:800, FL-261, Santa Cruz Biotecnology, Santa 
Cruz, USA). The presence of brown nuclear reactivity indicated PCNA-positive cells. The above 
was carried out in negative controls except that the primary antibody was replaced with a rabbit 
immunoglobulin G isotype antibody (1:800, ab37415, Abcam, Cambridge, UK). The number of 
cells immunopositive for PCNA was established using a standard light microscope at 400 X 
magnification. At least 400 epithelial and stromal cells from representative fields were counted 
by two independent observers blinded to the treatment condition, and the percentage of PCNA-
positive cells was calculated. 
 














For apoptosis quantification, sections were processed for TdT (terminal deoxynucleotidyl transferase) 
mediated dUDP nick-end labelling (TUNEL) staining using the In Situ Cell Death POD kit (Roche, 
Penzberg, Germany). Sections were treated according to the manufacturer´s instructions (Bilotas et al., 
2015). The number of TUNEL positive cells was established using a standard light microscope at 400 X 
magnification. At least 400 epithelial and stromal cells from representative fields were counted by two 




GraphPad PRISM software V4.0 (GraphPad Software Inc, La Jolla, CA, USA) was used for 
statistical analysis. Statistical comparisons between groups were carried out using parametric 
one-way analysis of variance followed by Tukey´s multiple comparison test. Student t-test was 
used for statistical comparisons between two groups, with Welch correction in groups with 
significantly different variances. Results were expressed as mean ± SEM. In all cases statistical 




Effect of carnosic acid, rosmarinic acid and wogonin on cell proliferation 
The effect of different concentrations of each natural compound on cell proliferation of primary 
cultures of endometrial stromal cells and on cultures of the T-HESC cell line are presented in 














endometriosis patients showed significantly lower percentage of cell proliferation than basal 
conditions (P <0.001 and P < 0.05, respectively, versus basal) (Figure 2A i–ii). Similar results 
were observed with the stromal cell line, where 10, 12.5 and 25 µg/ml of carnosic acid reduced 
the percentage of cell proliferation (P < 0.05, P < 0.001 and P < 0.001 respectively, versus basal) 
(Figure 2A iii). 
 
The highest concentrations of rosmarinic acid, 50 and 100 µg/ml, reduced cell proliferation in 
cultures from control women (P < 0.05 and P < 0.01 respectively, versus basal) (Figure 2B i), 
but only rosmarinic acid 100 µg/ml showed a significant effect in primary cell cultures from 
endometriosis patients (P < 0.05 versus basal) (Figure 2B ii). Similar to the results observed in 
primary cultures, rosmarinic acid 50 and 100 µg/ml showed a significant inhibition of T-HESC 
proliferation in a dose-dependent manner (P < 0.05 and P < 0.001, respectively versus basal) 
(Figure 2B iii). 
 
In the same way, wogonin 80 µM caused a reduction in the percentage of cell proliferation in 
cultures from control women (P < 0.001 versus basal) (Figure 2C i) and wogonin 40 and 80 µM 
induced cell proliferation inhibition in cultures from endometriosis patients (P < 0.05 versus 
basal (Figure 2C ii). In addition, wogonin 40, 80 and 160 µM caused a reduction on cell 
proliferation of T-HESC (P < 0.05, P < 0.001 and P < 0.001 respectively, versus basal) (Figure 
2C iii).  
 
These results demonstrate the effectiveness of these natural compounds on the diminution of the 














cell cultures and the T-HESC cell line were similar, we decided to continue the analysis only with 
the cell line. 
 
Effect of carnosic acid, rosmarinic acid and wogonin on cell cycle progression 
The mean per cent distribution of T-HESC in the different phases of the cell cycle is shown in 
Figure 3. G0/G1 phase decreased significantly after incubation with 2.5 and 5 µg/ml of carnosic 
acid (P < 0.01 and P < 0.001 versus control, respectively); 5 µg/ml of carnosic acid increased the 
DNA synthesis (S) phase (P < 0.05 versus control) and the percentage of cells in the G2/M phase 
was also significantly increased with both concentrations of this compound (P < 0.01 and P < 
0.001 versus control, respectively) (Figure 3A). It should be highlighted, that the concentrations 
of carnosic acid tested for cell cycle were lower than those that had an effect on cell proliferation. 
This is because, for this assay, the cells were stimulated during 48 h instead of 24 h, and higher 
concentrations provoked detaching of the cells and the analysis could not be conducted. 
After incubation with 50 and 100 µg/ml of rosmarinic acid, G0/G1 and G2/M phases of the cell 
cycle distribution of T-HESC were not altered (Figure 3B). A significant decrease in the S phase 
was induced with 50 µg/ml of rosmarinic acid compared with basal condition (Figure 3B). 
Similar to the results obtained with carnosic acid, G0/G1 phase decreased significantly after 
incubation with wogonin 40 and 80 µM (P < 0.001 versus control). In addition, wogonin 40 µM 
increased significantly the S phase (P < 0.05 versus control) and the percentage of cells in the 
G2/M phase was also significantly increased with wogonin 40 and 80 µM (P < 0.001 versus 














In summary, cell cycle analysis monitored by flow cytometry revealed that carnosic acid and 
wogonin induced cell cycle arrest at the G2/M phase. These results suggest that inhibition of 
endometrial stromal cells proliferation after treatment with these two compounds might be 
associated with cell cycle arrest induction. 
 
Effect of carnosic acid, rosmarinic acid and wogonin on intracellular reactive oxygen species 
production 
 
Carnosic acid did not alter the intracellular ROS levels (Figure 4A); however, rosmarinic acid 50 
and 100 µg/ml induced a significant decrease of fluorescence intensity, suggesting a strong anti-
oxidant power of this compound (P < 0.001 versus control) (Figure 4B). Conversely, after 
wogonin 80 µM treatment, ∆fluorescence was increased compared with untreated cells (P < 0.05, 
(Figure 4C). Pre-treatment with N-acetyl-cysteine slightly reduced wogonin-generated ROS to 
control levels. This result indicates that wogonin 80 µM had a pro-oxidant effect on T-HESC. 
 
Effect of carnosic acid, rosmarinic acid and wogonin on oestrogen receptor alpha expression and 
oestradiol secretion 
 
After 48 h treatment with the rosemary bioactive compounds carnosic acid and rosmarinic acid, 
oestrogen receptor alpha expression was slightly decreased but the differences were not 
statistically significant compared with the control group (Figure 5A–5B). On the other hand, 
wogonin 40 and 80 µM induced a significant decrease of oestrogen receptor alpha expression (P 
< 0.01 and P < 0.001, respectively) versus controls (Figure 5C). This result could be associated 
with wogonin anti-proliferative effect observed in T-HESC cell line. No differences, however, 
















No evidence of toxicity was found at the doses administered based on body weight (controlled 
every other day), food consumption, grooming behaviour, or activity levels compared with 
controls. Oestrous cycles were followed cytologically during treatments. No differences were 
detected between controls and treated mice, which suggests that treatments did not interfere with 
normal oestrous cycle progression (data not shown). 
 
Effect of carnosic acid, rosmarinic acid and wogonin on endometriotic-like lesion growth 
The highest doses of all treatments caused a statistically significant reduction in lesion size 
developed in mice. Administration of 20 mg/kg/day of carnosic acid, 3 mg/kg/day of rosmarinic 
acid and 20 mg/kg/day of wogonin diminished the volume of developed lesions (P < 0.01; P < 
0.05; P < 0.05 versus controls, respectively) (Figure 7 Ai–Ci). The number of established lesions 
observed after treatment, however, was similar to controls (Figure 7 Aii-Cii). 
 
Effect of carnosic acid, rosmarinic acid and wogonin on cell proliferation in endometriotic-like 
lesions 
 
Cell proliferation was evaluated by immunohistochemistry for PCNA (Figure 8). Results were 
expressed as the percentage of PCNA positive cells. As it can be seen in Figure 8 Ai–Ci, all 
treatments significantly decreased cell proliferation in endometriotic-like lesions compared with 
the control group (carnosic acid and wogonin: P < 0.05, rosmarinic acid: P < 0.001). 















Effect of carnosic acid, rosmarinic acid and wogonin on apoptosis in endometriotic-like lesions 
 
The effect of the natural compounds on apoptosis are presented in Figure 9. After carnosic acid 
treatment, a slight increase in the percentage of TUNEL positive cells in endometriotic-like 
lesions was observed, but the differences were not statistically significant compared with the 
control group (Figure 9A i). On the other hand, the highest dose of rosmarinic acid (3 
mg/kg/day) significantly increased the percentage of TUNEL-positive cells in endometriotic-like 
lesions (P < 0.05 versus control group) (Figure 9B i). In the same way, after treatment with 
wogonin (20 mg/kg/day) the percentage of TUNEL positive cells was significantly higher than 
the control group (P < 0.001) (Figure 9 Ci). Representative micrographs of TUNEL technique 
are shown in Figure 9 Aii–Cii. 
 
Discussion 
Current medical treatments available for endometriosis are not curative per se but they are 
nonetheless helpful to alleviate symptoms and prevent recurrence after surgery. Standard 
treatments for endometriosis involves laparoscopic ablation of endometriotic lesions and, in some 
cases, suppression of ovarian function with hormonal drugs, which also contribute to reduce the 
pain associated with endometriosis (Muñoz-Hernando et al., 2015). Additionally, pain 
management options include non-steroidal anti-inflamatory drugs and analgesics. Significant 
adverse effects are known when these drugs are used for a long period of time (Quaas et al., 
2015). Considering the disadvantages and limitations that conventional treatments carry, we 














efficiency, avoiding adverse effects and, as a desirable ultimate goal, preserving the chances of 
conceiving a successful pregnancy. 
 
Our in-vitro results demonstrated the effectiveness of carnosic acid and rosmarinic acid on 
inhibiting endometrial stromal cell proliferation and, in particular, on inducing G2/M cell cycle 
arrest by carnosic acid. These results are in accordance with those of Visanji et al. (2006) who 
demonstrated that the anti-proliferative effect of carnosic acid on human epithelial colorectal 
adenocarcinoma cells is associated with alterations of Cyclin A and Cyclin B1 levels. These 
proteins are responsible for cell cycle progression and a deregulated expression could cause cell 
cycle arrest predominantly at G2/M phase. In addition, Yesil-Celiktas et al. (2010) demonstrated 
significant anti-proliferative activity of carnosic acid in various human cancer cell lines. 
Deregulation of cell cycle and pro-apoptotic properties of these compounds have also been 
variously reported (Tai et al., 2012; López-Jiménez et al., 2013; Min et al., 2014). Nevertheless, 
their effects on endometriosis inhibition had not been investigated until now. 
 
Given the importance of oestrogen in this pathology, we decided to evaluate whether oestrogen 
receptor alpha expression was altered after treatment, but neither carnosic acid nor rosmarinic 
acid had an effect on the expression of this receptor. According to this result, we cannot account 
the inhibition of proliferation to be due to this pathway. A similar observation was made by 
Einbond et al. (2012) who demonstrated that carnosic acid inhibited the cell proliferation of on an 
oestrogen receptor alpha-negative breast cancer cell line (Einbond et al., 2012). 
 
Moreover, a strong anti-oxidant effect was observed after the stimulus with rosmarinic acid in T-














are in accordance with other investigators who had also confirmed the anti-oxidant property of 
rosemary. Cattaneo et al. (2015) have demonstrated an anti-oxidant effect of rosemary extract on 
melanoma cells. Similarly, it was discovered that rosmarinic acid was able to decrease ROS 
levels in endothelial cells and in a colon cancer cell line using concentrations ranging from 9 to 
100 μg/ml (Huang and Zheng, 2006; Xu et al., 2010). 
 
Endometriosis is associated with chronic inflammation and ROS increase; therefore, these results 
are encouraging as the anti-oxidant properties of polyphenols provide anti-inflammatory and 
chemopreventive abilities (Ravishankar et al., 2013; Stepanic et al., 2015). 
 
In addition to studies demonstrating the in-vitro effects of rosemary, several studies using animal 
models have also provided strong evidence for its anti-tumoural effect. A recently published 
review summarized the in-vivo anti-cancer properties of carnosic acid and rosmarinic acid 
(Moore et al., 2016). Studies supporting tumour growth inhibition have been conducted in animal 
models of prostate cancer (Petiwala et al., 2013; 2014) and colorectal cancer (Ngo et al., 2011) 
among others.  Similar to the results found in our in-vivo experiments, it was reported that oral 
administration of 100 mg/kg of rosemary extract for 22 days decreased the prostate cancer 
xenograft tumour size in 46% of athymic nude mice (Petiwala et al., 2014). In addition, 
intraperitoneal administration of 2 mg/kg of rosmarinic acid for 20 days significantly reduced the 
weight of solid lung carcinoma tumours developed in C57BL/6 mice as well as it effectively 
inhibited tumour metastasis in this model (Xu et al., 2010). 
 
The results obtained in our study using an in-vivo mouse model of endometriosis are congruent 














were effective in reducing the size of endometriotic-like lesions’. We observed a significant 
inhibition on cell proliferation after treatment with both polyphenols and apoptosis induction 
after treatment with rosmarinic acid, in endometriotic-like lesions developed in mice. 
 
Traditional Chinese medicine is prescribed in China for the treatment of a variety of 
inflammatory diseases, including endometriosis. Scutellaria baicalensis is one of the fundamental 
herbs present in Chinese medicine (Li-Weber, 2009; Lee et al., 2014), and wogonin is the main 
flavonoid isolated from the root of this plant. Our results provide evidence of an anti-proliferative 
effect of wogonin on human endometrial stromal cells added to cell cycle arrest induction at 
G2/M phase. 
 
Similarly, inhibition of cell proliferation, cell cycle arrest and apoptosis induction are some of the 
mechanisms that have been demonstrated to be altered after wogonin treatment in several cancer 
cell lines (Yu and Kim, 2011; Tao et al., 2014). Tao et al. (2014) reported that LL-202, a newly 
synthesized flavonoid derived from wogonin, induced arrest in cell cycle progression at G2/M 
phase in the breast cancer cell line MCF-7, which is in line with our results. More recently, 
Kavandi et al. (2015) demonstrated that Scutelaria baicalensis extract is able to inhibit 
proliferation of ovarian and endometrial cancer cell lines through inhibition of NFκB activation.  
 
Although flavonoids are commonly known for their anti-oxidant activity (Ravishankar et al., 
2013; Stepanic et al., 2015), many investigators have also demonstrated their pro-oxidant 
properties (Galati and O’Brien, 2004; Lin et al., 2008; Tao et al., 2014). This property can be 
useful in producing cytostatic effects specifically on cancer cells. The selectivity is due to the fact 














oncogenic stimulation, increased metabolic activity and mitochondrial malfunction (Hileman et 
al., 2004; Pelicano et al., 2004). As the endometrial cells at the ectopic site behave in a similar 
way to neoplasic cells, it is not surprising that treatments have similar effects. Our results provide 
evidence that wogonin promoted the intracellular ROS accumulation in T-HESC cells. We 
suggest that this pro-oxidant activity could induce cell death by apoptosis, a mechanism that has 
already been reported by other authors (Baumann et al., 2008; He et al., 2012; Yu and Kim, 
2011). Yu and Kim (2011) have shown that wogonin-induced apoptosis in human breast cancer 
cells is coupled with the generation of ROS and activation of ERK and p38. In the same way, He 
et al. (2012) have demonstrated that wogonin 10 μM was able to induce apoptosis of two cell 
lines, A549 and HeLa (pulmonary tumour cells and cervical cancer cells, respectively) through 
the intracellular accumulation of H2O2. 
 
Although wogonin decreased oestrogen receptor alpha expression in T-HESC cells, oestradiol 
secretion was not altered. This suggests that cell proliferation inhibition would not be mediated 
only through this pathway. In agreement, Chung et al. (2008) observed that the inhibition of cell 
proliferation induced by wogonin occurred both in oestrogen receptor alpha positive and negative 
mammary tumour cells, concluding that the inhibition of oestrogen receptor alpha expression 
would only partially contribute to the reduction of proliferation of positive oestrogen receptor 
alpha cells (Chung et al., 2008). 
 
Furthermore, we demonstrated the in-vivo effectiveness of this flavonoid on reduction of 
endometriotic-like lesions size and an anti-proliferative and pro-apoptotic effect of wogonin 
within the lesions. Studies published in the last few years prove the anti-tumour effect of 














wogonin was able to suppress growth of human T-cell leukaemia xenografts in immunodeficient 
mice (Baumann et al., 2008). In the same way, the in-vivo effect of oral wogonin administration 
was examined on human breast cancer xenografts growth in athymic nude mice. Treated mice 
showed inhibition of tumour growth by up to 88% without any toxicity after treatment (Chung et 
al., 2008). In BALB/c nude mice, growth of xenotransplanted MCF-7 tumours was also inhibited 
after 21 days of treatment with LW-213, a chemically synthesized flavonoid derived from 
wogonin. LW-213 inhibited cell proliferation in tumors and altered cell cycle regulatory proteins  
(Zhao et al., 2016). 
 
In conclusion, reported mechanisms by which the studied compounds exert their action are 
complex and variable. Cited studies definitely reveal the versatility of natural compounds in 
targeting multiple cell pathways, all of these especially important in cancer (Ovadje et al., 2015) 
and hence in endometriosis pathophysiology. 
 
To the best of our knowledge, this is the first study evaluating the effects of carnosic acid, 
rosmarinic acid and wogonin on the growth of human endometrial stromal cells and on the 
development of endometriotic-like lesions in a rodent model (Figure 10). These results are 
promising and lead to several open research questions that we are only beginning to explore. 
Better understanding of the basic mechanisms of action of these natural compounds, still 
unknown in endometrial cells, is needed to determine the potential usefulness of these natural 
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Key message 
Current medical treatments available for endometriosis have drawbacks. Carnosic acid, 
rosmarinic acid and wogonin have an inhibitory effect on in-vitro stromal endometrial growth 
and in-vivo endometriotic-like lesions development. The findings are promising and support 
further investigation of these novel, potentially safe and well-tolerated botanical products as 































Figure 2. Effect of carnosic acid, rosmarinic acid and wogonin on cell proliferation of primary 
cultures of endometrial stromal cells and T-HESC cell line. Cell proliferation was assessed by 
MTS assay. (A) Carnosic acid; (B) rosmarinic acid; (C) wogonin. (i) Endometrial stromal cells 
from control women (n = 7); (ii) endometrial stromal cells from patients with endometriosis (n = 
7); (iii) T-HESC (n = 5). Values of each treatment condition are expressed as a percentage of 
















Figure 3. Effect of carnosic acid, rosmarinic acid and wogonin on cell cycle progression. Cell 
cycle was monitored by flow cytometry staining the DNA with propidium iodide. (A) Carnosic 
acid (n = 7); (B) rosmarinic acid (n = 7); (C) wogonin (n = 6). *P < 0.05; **P < 0.01; ***P < 
0.001 versus control. 
 
Figure 4. Effect of carnosic acid, rosmarinic acid and wogonin on intracellular reactive oxygen 
species (ROS) production in treated T-HESC cells detected by using H2DCF-DA measured with 
a spectrofluorometer. (A) Carnosic acid (n = 7); (B) rosmarinic acid (n = 6); (C) wogonin (n = 9). 















Figure 5. Effects of carnosic acid, rosmarinic acid and wogonin on oestrogen receptor alpha 
protein expression in T-HESC cells. Western blot analysis was performed on cell homogenates 
from T-HESC cell cultures treated for 48h with (A) carnosic acid (0; 2.5; 5 µg/ml; n = 5); (B) 
rosmarinic acid (0; 50; 100 µg/ml; n = 6); and (C) wogonin (0; 40; 80 µM; n=5). The upper 
panels show quantification of results expressed as a percentage of basal values ± SEM. 
Representative blots are presented in lower panels. **P < 0.01; **P < 0.001 versus basal). 
 
Figure 6. Effects of wogonin on oestradiol levels in conditioned media of T-HESC cells treated 
with wogonin 40 and 80 µM or vehicle. Enzyme immunoassay was carried out in duplicate for 
each sample (n = 5); bars represent media + SEM. Values are expressed as percentage of vehicle 















Figure 7. The effect of carnosic acid, rosmarinic acid and wogonin on volume (i) and number (ii) 
of endometriotic-like lesions. Mice with surgically induced endometriosis were treated with: (A) 
carnosic acid: 2 mg/kg/day (n = 11) and 20 mg/kg/day (n = 10) or vehicle (control; n = 8); (B) 














wogonin: 20 mg/kg/day (n = 12) or vehicle (control, n = 11). *P < 0.05; **P < 0.01 versus 
control. 
 
Figure 8. The effect of carnosic acid, rosmarinic acid and wogonin on endometriotic-like lesion 
cell proliferation. Mice with surgically induced endometriosis were treated with: (A) carnosic 
acid: 2 mg/kg/day (n = 11) and 20 mg/kg/day (n = 10) or vehicle (control; n = 8); (B) rosmarinic 














mg/kg/day (n = 12) or vehicle (control, n = 11). Cell proliferation was evaluated by 
immunohistochemistry for proliferating cell nuclear antigen (PCNA) in endometriotic-like 
lesions and was quantified as a percentage of PCNA positive cells (Ai–Ci). *P < 0.05; **P < 
0.001 versus control (Aii–Cii). Photomicrographs of PCNA immunostaining are displayed. Inset: 
one section of each slide was incubated with a rabbit immunoglobulin G isotype antibody as a 















Figure 9. The effect of (A) carnosic acid, (B) rosmarinic acid and (C) wogonin on endometriotic-like 
lesions apoptosis. Mice with surgically induced endometriosis were treated with carnosic acid: 2 mg/kg/day 
(n = 11) and 20 mg/kg/day (n = 10) or vehicle (control: n = 8); rosmarinic acid: 1 mg/kg/day (n = 11) and 3 
mg/kg/day (n = 10) or vehicle (control: n = 8); wogonin: 20 mg/kg/day (n = 12) or 
vehicle (control, n = 11). Apoptosis was assessed by TdT (terminal deoxynucleotidyl transferase) 
mediated dUDP nick-end labelling (TUNEL) technique and was quantified in endometriotic-like 














(Aii–Cii) Photomicrographs of TUNEL staining are displayed. Black arrows indicate TUNEL 
positive cells. Inset: negative controls were incubated in the absence of TdT. Scale bar: 50 µm. 
Magnification: 400 X. 
 
Figure 10. Effects of carnosic acid, rosmarinic acid and wogonin on the growth of human 















Table 1. Treatment groups, dose and routes of administration. 
Treatment groups Dosage Duration, days Route of administration 
Control 
Vehicle (n = 8) 14 Intraperitoneal injection 
Vehicle (n = 11) 12 Intragastric gavage 
Rosmarinic acid 
1 mg/kg/day (n = 11) 14 
Intraperitoneal injection 
3 mg/kg/day (n = 10)  
Carnosic acid 
2 mg/kg/day (n = 11) 14 
Intraperitoneal injection 
20 mg/kg/day (n = 10)  
Wogonin 20 mg/kg/day (n = 12) 12  Intragastric gavage 
 
 
 
 
 
